Redox 1H FY26 Results: Investor Briefing & Q&A

Redox Limited (ASX:RDX), a leading distributor of chemicals and ingredients, is releasing its first-half fiscal 2026 (1H FY26) results on February 19, 2026. This update arrives as markets assess whether the industrial sector's tentative recovery is gaining traction.

In the prior full year (FY2025, ended June 2025), Redox posted sales revenue over $1.24 billion, a 9.4% increase year-over-year, fueled by organic expansion and acquisitions. Gross margins held at 21.6%—within the long-term 20-22% band—but were squeezed by a mix shift toward higher-volume, lower-margin commodities and ongoing inflation in logistics and storage costs. Management flagged early positive signals entering FY2026, including 13% volume growth in the first quarter and optimism that moderating inflation could deliver a tailwind.

The current half-year period (July–December 2025) is pivotal: it tests whether demand from key end-markets—food and beverage, water treatment, mining, manufacturing, and agriculture—has stabilised or improved after several years of volatility. Chemical distributors like Redox are sensitive barometers for industrial activity; their results reflect real-world pressures such as supply-chain normalisation, interest-rate effects on customer capex, and regional variations across Australasia, Southeast Asia, and the US.

For customers reliant on consistent chemical supply, Redox's performance influences input costs and availability in essential supply chains. For investors, with the stock trading on a P/E near 18 and offering a dividend yield around 4.8%, the figures will clarify if margin stability and cash generation are tracking toward management's expectations or facing renewed challenges in a still-uncertain macro environment.